The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I molecular adaptive clinical study to evaluate safety and tolerability of BPM31510-IV in advanced solid tumors: Final study results.
 
Niven R. Narain
Employment - Berg Pharma
Leadership - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
Patents, Royalties, Other Intellectual Property - Berg Pharma
 
Vivek Subbiah
Consulting or Advisory Role - MedImmune
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Takeda (Inst); Vegenics (Inst)
Travel, Accommodations, Expenses - Bayer; PharmaMar
 
David S. Hong
Stock and Other Ownership Interests - MolecularMatch; Oncorena
Honoraria - Adaptimmune; Baxter; Bayer; Merrimack
Consulting or Advisory Role - Baxter; Bayer; Guidepoint Global; Janssen
Research Funding - Abbvie; Adaptimmune; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Genentech; Genmab; Ignyta; Infinity Pharmaceuticals; Kite, a Gilead company; Kyowa Hakko Kirin; Lilly; Loxo; MedImmune; Merck; Mirati Therapeutics; miRNA Therapeutics; Molecular Templates; Novartis; Pfizer; Takeda
Travel, Accommodations, Expenses - Loxo; miRNA Therapeutics
Other Relationship - Oncorena
 
David Lucius
Employment - Berg Pharma
 
Viatcheslav R Akmaev
Employment - Berg Pharma
Leadership - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
Patents, Royalties, Other Intellectual Property - Berg Pharma
Travel, Accommodations, Expenses - Berg Pharma
 
Michael A Kiebish
Employment - Berg Pharma
Leadership - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
Research Funding - Berg Pharma
Patents, Royalties, Other Intellectual Property - Berg Pharma
Travel, Accommodations, Expenses - Berg Pharma
 
Gregory M Miller
Employment - Berg Pharma; Bluebird Bio (I)
Stock and Other Ownership Interests - Berg Pharma; Bluebird Bio (I)
 
Eric Milliman
Employment - Berg Pharma
 
Leonardo O Rodrigues
No Relationships to Disclose
 
Lixia Zhang
Employment - Berg Pharma
Travel, Accommodations, Expenses - Berg Pharma
 
Rangaprasad Sarangarajan
Employment - Berg Pharma
Leadership - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
Patents, Royalties, Other Intellectual Property - Berg Pharma